Orby.co: The Brazilian Neurotech Startup Using AI to Restore Human Movement
At just 27 years old, Duda Franklin has already spent more than a decade immersed in artificial intelligence, programming, and biomedical engineering. Now, the scientist from Rio Grande do Norte is on the verge of launching her first major commercial venture — a neurotech startup called Orby.co that could fundamentally change the way we think about physical rehabilitation, chronic pain management, and athletic performance.
Orby.co represents one of the most compelling intersections of neuroscience and artificial intelligence to emerge from Brazil's growing startup ecosystem. Its flagship product, the Ortech platform, applies AI-driven electrostimulation directly to the human body, acting — as Franklin herself describes it — as "a layer of intelligence applied to the body." The implications are enormous, both for patients recovering from injuries and for high-performance athletes seeking a competitive edge.
Who Is Duda Franklin?
To understand Orby.co, it helps to understand its founder. Duda Franklin began her journey into technology at the age of 14, enrolling in a technical computing course in her home state of Rio Grande do Norte. What started as early curiosity quickly evolved into a deep academic commitment. She went on to earn a degree in biomedical engineering and completed a master's degree in neuroengineering — both at the Federal University of Rio Grande do Norte (UFRN) in Natal.
Her academic background placed her at the crossroads of two rapidly advancing fields: neuroscience and artificial intelligence. Rather than pursuing a purely academic career, Franklin chose to take her research out of the laboratory and into the marketplace. As co-founder and CEO of Orby.co, she is now translating years of scientific study into a product with real-world, life-changing applications.
Franklin's profile is notable not just for her technical credentials, but for what she represents in the broader context of Brazil's tech industry: a young woman from the country's northeast region building a globally competitive deep-tech company from the ground up.
What Is Ortech and How Does It Work?
At the heart of Orby.co is the Ortech platform, an electrostimulation system that leverages artificial intelligence to deliver targeted therapeutic sessions. Electrostimulation itself is not a new concept — electrical currents have been used in physical therapy for decades. What sets Ortech apart is the intelligence layer built on top of it.
Traditional electrostimulation devices deliver standardized pulses that do not adapt to the individual user. Ortech changes this by using AI algorithms to analyze how a patient's body responds to stimulation in real time, adjusting parameters dynamically to optimize outcomes. The result is a highly personalized therapeutic experience that goes far beyond what conventional devices can offer.
The platform has three primary use cases:
- Movement rehabilitation: Helping patients recover motor function lost due to injury, stroke, or neurological conditions. The system stimulates the nerves and muscles involved in movement, encouraging neural pathways to rebuild and strengthen over time.
- Chronic pain relief: Offering a non-pharmacological alternative for individuals suffering from long-term pain conditions. By modulating the body's pain signals through targeted electrical stimulation, Ortech provides relief without the side effects associated with medication.
- Athletic performance enhancement: Supporting sports professionals in their physical preparation and recovery routines. By accelerating muscle activation and reducing post-exercise recovery time, the platform offers performance benefits to competitive athletes.
The breadth of these applications gives Orby.co access to multiple high-value markets simultaneously — a strategic advantage that sets the startup apart from more narrowly focused medical device companies.
Why AI-Powered Neurotech Matters Right Now
The global neurotech industry is undergoing a period of rapid expansion. Advances in machine learning, miniaturized hardware, and wearable technology are converging to create a new generation of devices that can interact with the human nervous system in ways that were previously impossible. Market research consistently places the neurotechnology sector on an upward trajectory, with rehabilitation technology representing one of its fastest-growing segments.
In Brazil, the stakes are particularly high. The country has a large aging population, a substantial burden of chronic disease, and significant demand for affordable, effective rehabilitation solutions. At the same time, Brazil's sports culture — from football to mixed martial arts — creates a natural market for performance-enhancing recovery tools. Orby.co is positioned to serve both ends of this spectrum.
Furthermore, the application of AI to medical devices is a regulatory and commercial frontier that is still being defined globally. Startups like Orby.co that establish credibility and clinical evidence early are well-placed to become category leaders as the market matures.
A Startup Built on Scientific Rigor
One of the distinguishing features of Orby.co is its deep roots in academic research. Unlike many health-tech ventures that rely primarily on software and consumer-facing design, Orby.co's technology has been developed from the ground up by researchers with formal training in neuroengineering. This scientific foundation gives the company a durable competitive advantage — its intellectual property is built on domain expertise that is difficult to replicate quickly.
Franklin's dual background in biomedical engineering and neuroengineering means she can communicate credibly with both clinical stakeholders and technology investors. This rare combination of skills is essential for navigating the complex regulatory, clinical, and commercial landscape that medical device startups must traverse.
Looking Ahead: What's Next for Orby.co
As Orby.co moves toward its commercial launch, the startup joins a growing cohort of Brazilian deep-tech companies demonstrating that world-class innovation is not confined to Silicon Valley or European tech hubs. With a founder who has been building her expertise since her early teenage years and a product designed to address real, pressing health challenges, Orby.co is one of the most exciting neurotech ventures to watch in Latin America.
Whether the goal is helping a stroke survivor regain the ability to move their arm, offering a chronic pain patient an alternative to long-term medication, or giving a professional athlete the recovery edge that separates good from great, Orby.co's Ortech platform is designed to deliver meaningful, measurable impact. In a world increasingly defined by the fusion of biology and technology, that is a powerful place to be.